Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MC2-25 cream versus vehicle for chronic kidney disease-associated pruritus
2022-500044-38-01Phase 2Completed
- Sponsor
- MC2 Therapeutics
- Start
- Jan 2023
- Modality
- Small Molecules, Peptides
- Countries
- 4
01
Overview
Phase 2, randomised, double-blind trial in chronic kidney disease (CKD) comparing MC2-25 cream with Vehicle placebo (2 arms). Primary endpoint: Mean change in weekly mean WI-NRS from baseline to Week 12. Started Jan 2023; status: completed.
02
Drugs
alanyl glutamine
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2022-500044-38-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-500044-38-01.